AISAP's AI Technology Featured in WHO's Healthcare Innovations Report

AISAP's Impact in Modern Healthcare

In a groundbreaking report released by the World Health Organization (WHO), AISAP has been prominently featured for its innovative AI platform designed specifically for point-of-care ultrasound (POCUS). This recognition comes as AISAP is positioned as a frontrunner in redefining cardiac diagnosis through artificial intelligence technology in healthcare settings.

The WHO report, titled "Bridging Theory and Practice," includes a case study detailing AISAP's collaboration with Sheba Medical Center, recognized as one of the leading hospitals globally. Within this framework, AISAP's AI-enhanced cardiac ultrasound system has been utilized effectively, showcasing a significant leap in diagnostic speed and accuracy. Between July 2022 and December 2023, 660 patients were evaluated using this advanced AI technology, which allowed physicians without formal sonography training to conduct cardiac assessments efficiently.

The study published in Mayo Clinic Proceedings Digital Health reveals that AISAP’s AI-driven system identified clinically relevant cardiac findings in nearly 30% of the patients, with 147 diagnoses being entirely new. Notably, this led to important treatment modifications for 49 of those assessed and prompted interventional procedures for 9 patient cases.

One of the standout aspects of the AISAP’s technology is its remarkable diagnostic accuracy. In a segment of patients validated against formal echocardiograms, the AI-enhanced ultrasound demonstrated an astounding 100% sensitivity for detecting significant left ventricular dysfunction and 96.9% specificity for identifying issues such as aortic stenosis. These results validate the platform’s potential and highlight the life-saving possibilities it introduces to patient care.

AISAP’s Chief Medical Officer, Robert Klempfner, emphasized the significance of this WHO recognition. He stated, "Being recognized by the World Health Organization validates what we've seen firsthand at Sheba. AI-guided POCUS can bring specialist-level cardiac diagnostics to any clinician, at any bedside, in minutes rather than hours. This is what validated AI can deliver: rapid, expert-level care directly to patients, across hospital departments."

Furthermore, during the clinical study, over 30% of patients experienced treatment changes, early discharges, or transitions in their care facilitated by scans completed in under five minutes. By the second quarter of 2025, the AISAP platform had been employed for more than 3,000 scans across multiple departments at Sheba Medical Center, with 150 trained clinicians seamlessly integrating it into their clinical workflows.

AISAP received FDA clearance in September 2024 for its AISAP CARDIO V1.0 system, supported by a comprehensive U.S. multicenter study that demonstrated over 93% sensitivity and specificity in detecting significant cardiac conditions. Meanwhile, Sheba Medical Center reported operational insights indicating the effectiveness of the platform beyond the peer-reviewed study results, solidifying its importance in daily clinical practice.

The WHO's "Bridging Theory and Practice" report is essential reading for understanding how AI is transforming healthcare landscape and the direct impact it has on patient outcomes. You can access the full report at WHO's official site.

In summary, AISAP’s technology is not merely an advancement in ultrasound imaging; it represents a significant shift in how cardiac diagnostics can be delivered. Recognized on a global platform, AISAP is at the forefront of a new era in healthcare, where rapid and accurate diagnosis can significantly enhance patient care and outcomes.